CUV 0.60% $15.04 clinuvel pharmaceuticals limited

Wolgen

  1. 68 Posts.
    lightbulb Created with Sketch. 51
    It appears from the latest newsletter that Wolgen has adopted my 16 catalyst record keeping. Thank you Dr Wolgen.

    Question: Did they just start a new adolescent trial for the label extension? Is this really starting a new trial for the label extension we expected 1 year ago? That should be a minus 1 on Wolgen's catalyst checklist.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.